BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18295464)

  • 1. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
    Jain AK; Khar RK; Ahmed FJ; Diwan PV
    Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles.
    Chalasani KB; Russell-Jones GJ; Jain AK; Diwan PV; Jain SK
    J Control Release; 2007 Sep; 122(2):141-50. PubMed ID: 17707540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.
    Chalasani KB; Russell-Jones GJ; Yandrapu SK; Diwan PV; Jain SK
    J Control Release; 2007 Feb; 117(3):421-9. PubMed ID: 17239471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles.
    Shi K; Cui F; Yamamoto H; Kawashima Y
    Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of in situ gel system for nasal insulin delivery.
    Agrawal AK; Gupta PN; Khanna A; Sharma RK; Chandrawanshi HK; Gupta N; Patil UK; Yadav SK
    Pharmazie; 2010 Mar; 65(3):188-93. PubMed ID: 20383938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization.
    Venugopalan P; Sapre A; Venkatesan N; Vyas SP
    Pharmazie; 2001 Mar; 56(3):217-9. PubMed ID: 11265586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
    Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
    Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between drug effects and particle size of insulin-loaded bioadhesive microspheres.
    Pan Y; Zheng JM; Zhao HY; Li YJ; Xu H; Wei G
    Acta Pharmacol Sin; 2002 Nov; 23(11):1051-6. PubMed ID: 12421485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
    Damgé C; Maincent P; Ubrich N
    J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.